{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:56Z","timestamp":1790223416786,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":700,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA122569"],"award-info":[{"award-number":["R01CA122569"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["P30 CA010815"],"award-info":[{"award-number":["P30 CA010815"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["RO1 CA 132098"],"award-info":[{"award-number":["RO1 CA 132098"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/jid.2013.279","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T09:49:52Z","timestamp":1371808192000},"page":"229-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["CD164 and FCRL3 Are Highly Expressed on CD4+CD26 \u2212 T Cells in S\u00e9zary Syndrome Patients"],"prefix":"10.1016","volume":"134","author":[{"given":"Maria","family":"Wysocka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Kossenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice M.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Troxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzvete","family":"Dentchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Ise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Showe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2013.279_bb0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/jid.2010.404","article-title":"Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sezary syndrome patients","volume":"131","author":"Bensussan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.279_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.279_bb0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0025","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2010-08-302034","article-title":"Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface","volume":"117","author":"Chung","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0030","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1182\/blood-2010-05-287664","article-title":"High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma","volume":"117","author":"Clark","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0035","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","article-title":"New markers for minimal residual disease detection in acute lymphoblastic leukemia","volume":"117","author":"Coustan-Smith","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0040","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.leu.2400745","article-title":"Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk","volume":"11","author":"Fargnoli","year":"1997","journal-title":"Leukemia"},{"key":"10.1038\/jid.2013.279_bb0045","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.279_bb0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2407-6-195","article-title":"The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis","volume":"6","author":"Havens","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1038\/jid.2013.279_bb0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaad.2005.06.001","article-title":"Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sezary syndrome","volume":"53","author":"Introcaso","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2013.279_bb0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","article-title":"Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood","volume":"115","author":"Jones","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2013.279_bb0065","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.20021726","article-title":"Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma","volume":"197","author":"Kari","year":"2003","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2013.279_bb0070","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2013.279_bb0075","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/cyto.a.22095","article-title":"Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes","volume":"81","author":"Leccia","year":"2012","journal-title":"Cytometry A"},{"key":"10.1038\/jid.2013.279_bb0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/oxfordjournals.jbchem.a022704","article-title":"The ratio of splicing variants of MGC-24\/CD164, a sialomucin, correlates with the metastatic potential of colorectal carcinomas","volume":"127","author":"Matsui","year":"2000","journal-title":"J Biochem"},{"key":"10.1038\/jid.2013.279_bb0085","first-page":"131","article-title":"Cutaneous T-cell lymphoma","volume":"1","author":"Murphy","year":"1988","journal-title":"Adv Pathol"},{"key":"10.1038\/jid.2013.279_bb0090","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.4049\/jimmunol.0802230","article-title":"Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells","volume":"182","author":"Nagata","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.279_bb0095","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0100","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome","volume":"122","author":"Poszepczynska-Guigne","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.279_bb0110","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in Sezary syndrome","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.279_bb0115","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/archdermatol.2010.200","article-title":"Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression","volume":"146","author":"Samimi","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2013.279_bb0120","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3324\/haematol.2010.026260","article-title":"The role of 9-O-acetylated ganglioside D3 (CD60) and \u03b14\u03b21 (CD49d) expression in predicting the survival of patients with Sezary syndrome","volume":"95","author":"Scala","year":"2010","journal-title":"Haematologica"},{"key":"10.1038\/jid.2013.279_bb0125","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/ijc.23042","article-title":"Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia\/lymphoma","volume":"121","author":"Shimauchi","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2013.279_bb0130","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1158\/0008-5472.CAN-09-1378","article-title":"Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease","volume":"69","author":"Showe","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2013.279_bb0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","article-title":"Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7","volume":"152","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.279_bb0140","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2230.2005.01904.x","article-title":"Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sezary syndrome","volume":"30","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1038\/jid.2013.279_bb0145","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.279_bb0150","first-page":"7122","article-title":"Aberrant expression of T-plastin in Sezary cells","volume":"63","author":"Su","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2013.279_bb0155","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.4049\/jimmunol.0903943","article-title":"Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1","volume":"184","author":"Swainson","year":"2010","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.279_bb0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood.V92.3.849","article-title":"CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21","volume":"92","author":"Watt","year":"1998","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0165","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2004-03-1190","article-title":"Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15","volume":"104","author":"Wysocka","year":"2004","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0170","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2003-04-1044","article-title":"Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma","volume":"102","author":"Yawalkar","year":"2003","journal-title":"Blood"},{"key":"10.1038\/jid.2013.279_bb0175","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood.V92.8.2613","article-title":"The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis","volume":"92","author":"Zannettino","year":"1998","journal-title":"Blood"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15364848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15364848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:05:52Z","timestamp":1743959152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15364848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022202X15364848"],"URL":"https:\/\/doi.org\/10.1038\/jid.2013.279","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD164 and FCRL3 Are Highly Expressed on CD4+CD26 \u2212 T Cells in S\u00e9zary Syndrome Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2013.279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}